Ccr2-flox Mouse

Ccr2, namely C-C chemokine receptor 2, is a cell surface receptor belonging to the chemokine receptor superfamily. It is mainly expressed on cells such as monocytes, macrophages, T cells, and neurons, and binds to its ligand, monocyte chemoattractant protein-1 (MCP-1), to participate in the regulation of inflammatory responses and immune cell migration. Activation of Ccr2 can promote the movement of these cells to the inflamed sites, thus playing an important role in inflammation and immune responses. In addition, Ccr2 is also associated with the occurrence and development of various diseases, such as atherosclerosis, tumor metastasis, osteoporosis, and abdominal aortic aneurysm. Therefore, the study of Ccr2 is of great significance for understanding the pathogenesis of diseases and finding new treatment strategies.

According to references, Ccr2 plays an important role in various diseases. For example, in subacute subdural hematoma (SAH), the expression of Ccr2 is upregulated and is closely related to neuroinflammation and neuronal apoptosis. Studies have shown that inhibiting Ccr2 can reduce neuroinflammation, decrease neuronal apoptosis, and improve the prognosis of SAH patients [1]. In addition, Ccr2 is also related to the development of atherosclerosis. Research has found that after acute kidney injury (AKI), CCR2+ bone marrow cells can promote the formation of atherosclerotic plaques [2]. Moreover, Ccr2 gene polymorphism is associated with the severity of ovarian cancer. Studies have found that the CCR2 (+190 G/A) GG genotype is associated with the advanced stage of ovarian cancer, while the A allele is associated with the early stage of ovarian cancer [3]. In addition, Ccr2 gene polymorphism is also associated with the risk of oral squamous cell carcinoma (OSCC). Research has found that the CCR2 V64I gene polymorphism can increase the risk of OSCC [4].

In summary, Ccr2 plays an important role in various diseases, including subacute subdural hematoma, atherosclerosis, ovarian cancer, and oral squamous cell carcinoma. The study of Ccr2 helps to deeply understand the pathogenesis of these diseases and find new treatment strategies.